The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 06, 2018
Filed:
Jan. 16, 2014
Applicant:
Metabolon, Inc., Durham, NC (US);
Inventors:
Walter Gall, Chapel Hill, NC (US);
Jeffery Edmond Cobb, Chapel Hill, NC (US);
Kirk Lane Pappan, Rougemont, NC (US);
Assignee:
Metabolon, Inc., Morrisville, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); G06F 19/00 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); G01N 33/5308 (2013.01); G06F 19/3431 (2013.01); G01N 2333/46 (2013.01); G01N 2800/042 (2013.01); G01N 2800/32 (2013.01); G01N 2800/324 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01); G01N 2800/60 (2013.01);
Abstract
Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.